Efficacy of early Hyperbaric Oxygen Therapy in Central Retinal Artery Occlusion
International Journal of Clinical and Experimental Ophthalmology · 2017
DOI: 10.29328/journal.hceo.1001003 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Ophthalmology, 2017. Verfasst von Ayse Gul Kocak Altintas und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A 60-year-old woman had central retinal artery occlusion (CRAO) presented to the ophthalmology department with a sudden, painless loss of vision. Her initial visual acuity was light perception and she treated with hyperbaric oxygen therapy (HBOT) 4 hours after the development of visual symptoms. Systemic risk factors were not found so she was diagnosed as having idiopathic CRAO. Her vision improved from light perception to 20/50 after the HBOT. Any complications such as neovascularization were not developed until the last follow up visit of 8th months.
Zitieren
APA
Altintas, A. G. K., & Citirik, M. (2017). Efficacy of early Hyperbaric Oxygen Therapy in Central Retinal Artery Occlusion. International Journal of Clinical and Experimental Ophthalmology. https://doi.org/10.29328/journal.hceo.1001003
Vancouver
Altintas AGK, Citirik M. Efficacy of early Hyperbaric Oxygen Therapy in Central Retinal Artery Occlusion. International Journal of Clinical and Experimental Ophthalmology. 2017. doi:10.29328/journal.hceo.1001003
BibTeX
@article{Altintas2017,
author = {Altintas, Ayse Gul Kocak and Citirik, Mehmet},
title = {Efficacy of early Hyperbaric Oxygen Therapy in Central Retinal Artery Occlusion},
journal = {International Journal of Clinical and Experimental Ophthalmology},
year = {2017},
doi = {10.29328/journal.hceo.1001003}
}
EUVIMED